Ritonavir Completed Phase 4 Trials for HIV-Associated Lipodystrophy Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00135356Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome